Zacks Research Has Optimistic Opinion of MOH FY2026 Earnings

Molina Healthcare, Inc (NYSE:MOH – Free Report) – Investment analysts at Zacks Research increased their FY2026 earnings per share (EPS) estimates for shares of Molina Healthcare in a research report issued to clients and investors on Wednesday, November 11th. Zacks Research analyst Team now expects that the company will earn $5.27 per share for the year, up from their prior estimate of $5.25. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Molina Healthcare’s current full-year earnings is $5.30 per share. Zacks Research also issued estimates for Molina Healthcare’s Q4 2026 earnings at $0.52 EPS, Q2 2027 earnings at $2.54 EPS, Q4 2027 earnings at $2.36 EPS, FY2027 earnings at $9.55 EPS, Q1 2028 earnings at $2.95 EPS, Q2 2028 earnings at $2.26 EPS and FY2028 earnings at $12.44 EPS.

Several other equities analysts have also commented on the company. Royal Bank Of Canada raised their price objective on Molina Healthcare from $218.00 to $222.00 and gave the company a “sector perform” rating in a research report on Friday, October 23rd. Morgan Stanley upped their target price on shares of Molina Healthcare from $167.00 to $192.00 and gave the stock an “equal weight” rating in a research report on Friday, October 23rd. Cantor Fitzgerald reiterated a “neutral” rating on shares of Molina Healthcare in a research note on Friday, October 9th. UBS Group increased their price target on shares of Molina Healthcare from $202.00 to $225.00 and gave the stock a “neutral” rating in a research note on Friday, October 23rd. Finally, Mizuho set a $255.00 price target on shares of Molina Healthcare in a research report on Friday, October 23rd. Three research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, Molina Healthcare has an average rating of “Hold” and a consensus price target of $213.88.

Read Our Latest Stock Analysis on MOH

Molina Healthcare Price Performance

MOH opened at $233.08 on Monday. The stock has a fifty day simple moving average of $203.21 and a two-hundred day simple moving average of $185.92. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.95. The company has a market cap of $12.17 billion, a price-to-earnings ratio of 104.93, a price-to-earnings-growth ratio of 12.38 and a beta of 0.75. Molina Healthcare has a 12-month low of $121.06 and a 12-month high of $244.89.

Molina Healthcare (NYSE:MOH – Get Free Report) last released its earnings results on Wednesday, October 21st. The company reported $0.89 EPS for the quarter, beating analysts’ consensus estimates of $0.79 by $0.10. Molina Healthcare had a positive return on equity of 2.50% and a negative net margin of 0.11%. The company had revenue of $11.08 billion during the quarter, compared to analysts’ expectations of $10.86 billion. During the same quarter last year, the business posted $1.84 EPS. The firm’s revenue for the quarter was down 3.4% compared to the same quarter last year.

Institutional Investors Weigh In On Molina Healthcare

A number of institutional investors have recently modified their holdings of MOH. Fortitude Family Office LLC raised its position in shares of Molina Healthcare by 63.7% in the 3rd quarter. Fortitude Family Office LLC now owns 131 shares of the company’s stock worth $25,000 after purchasing an additional 51 shares during the last quarter. Elevation Wealth Partners LLC boosted its stake in Molina Healthcare by 118.2% in the 2nd quarter. Elevation Wealth Partners LLC now owns 144 shares of the company’s stock worth $33,000 after purchasing an additional 78 shares in the last quarter. Global Retirement Partners LLC bought a new position in Molina Healthcare in the 2nd quarter worth about $39,000. Versant Capital Management Inc grew its position in Molina Healthcare by 341.6% during the 2nd quarter. Versant Capital Management Inc now owns 340 shares of the company’s stock valued at $78,000 after purchasing an additional 263 shares during the last quarter. Finally, Contravisory Investment Management Inc. purchased a new stake in Molina Healthcare during the 2nd quarter valued at about $89,000. 98.50% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Molina Healthcare news, Director Richard M. Schapiro sold 782 shares of Molina Healthcare stock in a transaction on Tuesday, November 10th. The stock was sold at an average price of $203.94, for a total transaction of $159,481.08. Following the completion of the transaction, the director owned 11,833 shares in the company, valued at approximately $2,413,222.02. The trade was a 6.20% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Dale B. Wolf sold 1,600 shares of Molina Healthcare stock in a transaction on Friday, November 13th. The shares were sold at an average price of $206.12, for a total value of $329,792.00. Following the transaction, the director owned 14,337 shares of the company’s stock, valued at $2,955,142.44. The trade was a 10.04% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 11,084 shares of company stock worth $2,273,419. 1.44% of the stock is currently owned by corporate insiders.

More Molina Healthcare News

These are some of the MOH news items that stood out recently:

  • Positive Sentiment: Investors rotated into defensive healthcare names amid weakness in riskier parts of the market, lifting Molina alongside the sector. Recent earnings results and reaffirmed 2026 adjusted earnings guidance may also be supporting sentiment. Sector news
  • Neutral Sentiment: Director Steven Orlando sold 702 shares for about $160,000, reducing his direct stake by 3.84%; he retained 17,569 shares after the transaction. The sale is modest relative to his remaining ownership. SEC filing
  • Negative Sentiment: Zacks Research cut its Q4 2026 EPS estimate to $0.52 from $0.69, tempering the positive impact of its upward revisions to later-period estimates.

About Molina Healthcare

(Get Free Report)

Molina Healthcare, Inc. is a managed care company that provides health insurance plans primarily to people covered by government-sponsored programs. Its offerings include Medicaid plans, Medicare plans for eligible individuals and dual-eligible members, and health plans sold through government marketplaces under the Affordable Care Act. The company was founded in 1980 by physician C. David Molina in Long Beach, California, initially serving low-income families through community clinics. It later shifted its focus to providing managed health care, with Medicaid becoming a central part of its business.

Featured Articles

Earnings History and Estimates for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.